Aug 08, 2024 / 08:30PM GMT
Operator
Good day, and welcome to the Nephros Inc. second-quarter 2024 financial results conference call. (Operator Instructions) Please note, today's event is being recorded.
I'd now like to turn the conference over to Kirin Smith with Investor Relations. Please go ahead.
Kirin Smith - PCG Advisory - Investor Relations
Good afternoon, everyone, and welcome to Nephros's Q2 2024 earnings conference call. This is Kirin Smith with PCG Advisory. Thank you, all, for participating in Nephros's second-quarter 2024 conference call.
Before we begin, I would like to remind you that this call will include forward-looking statements regarding the operations and future results of Nephros. For a discussion of these forward-looking statements, please review Nephros's SEC filings, including Forms 10-K and 10-Q, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Factors that may affect the company's results include, but are not limited to, Nephros's ability to
Q2 2024 Nephros Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot